Global Therapeutic Protein Market

$2,400.00

产品代码: MGH01781 行业: 地区:

The term therapeutic protein was first used to describe medicines that are genetically engineered versions of naturally occurring human proteins. Therapeutic proteins can be used to replace a protein that is abnormal or deficient in a particular disease. They can also augment the body’s supply of a beneficial protein to help reduce the impact of disease or chemotherapy. The global therapeutic protein market is anticipated to increase by USD 146 十亿直到 2028 年均增长 7.8 根据 Gen Consulting 公司的最新报告.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global therapeutic protein market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the therapeutic protein industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, 过程, 和地区. The global market for therapeutic protein can be segmented by product: 单克隆抗体, 疫苗, peptide hormones, coagulation factors, cytokines, therapeutic enzymes, peptide antibiotics. The monoclonal antibodies segment held the largest share of the global therapeutic protein market in 2021 预计在预测期内将持有其份额. Therapeutic protein market is further segmented by process: cell culture, microbial fermentation, natural source, 其他的. 全球范围, the cell culture segment made up the largest share of the therapeutic protein market. 根据地区, the therapeutic protein market is segmented into: 北美, 亚太地区, 欧洲, 世界其他地区 (排).

副产品:
– 单克隆抗体
– 疫苗
peptide hormones
coagulation factors
cytokines
therapeutic enzymes
peptide antibiotics

By process:
cell culture
microbial fermentation
natural source
– 其他的

按地区:
– 北美
– 亚太地区
– 欧洲
– 世界其他地区 (排)

The report also provides a detailed analysis of several leading therapeutic protein market vendors that include AbbVie Inc., 亚力兄制药公司, 公司, Amgen Inc., BioMarin Pharmaceutical Inc., 百时美施贵宝公司, CSL Limited, Eli Lilly and Company, F. 罗氏霍夫曼公司, 葛兰素史克公司, Grifols, S.A., 约翰逊 & 约翰逊, 默克公司, 诺华公司, Novo Nordisk A/S, 辉瑞公司, Sanofi SA, Takeda Pharmaceutical Company Limited, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global therapeutic protein market.
To classify and forecast the global therapeutic protein market based on product, 过程, 地区.
To identify drivers and challenges for the global therapeutic protein market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global therapeutic protein market.
To identify and analyze the profile of leading players operating in the global therapeutic protein market.

为什么选择这份报告
Gain a reliable outlook of the global therapeutic protein market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Therapeutic Protein Market

对这份报告感兴趣? 立即获取免费样品!
Global Therapeutic Protein Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

7.8%

页数

88

行业参与者

艾伯维公司, 亚力兄制药公司, Amgen Inc., BioMarin Pharmaceutical Inc., 百时美施贵宝公司, CSL Limited, Eli Lilly and Company, F. 罗氏霍夫曼公司, 葛兰素史克公司, Grifols S.A., 约翰逊 & 约翰逊, 默克公司, 诺华公司, Novo Nordisk A/S, 辉瑞公司, Sanofi SA, Takeda Pharmaceutical Company Limited

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Therapeutic Protein Market

请填写我们的表格,我们会尽快回复您.